Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1738 results
Horizon Pharma gets USPTO patent for PENNSAID (diclofenac sodium topical solution) 2%
Horizon Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for US patent application number 14/705,649 (U.S. publication number 2015-0231264), entitled "Diclofenac Topical Formulation" that covers its US approved product PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%).
Automation > IT & Software > News
Humana unveils real-time prescription drug benefit service
Humana has announced a real-time prescription drug benefit service that gives doctors information about their Humana patients’ drug coverage, pricing and network pharmacy options all while the patient is in the exam room.
Automation > IT & Software > News
Quintiles, IMS Health partner to advance use of real-world evidence in late-stage clinical research
Quintiles and IMS Health have formed a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research.
Automation > IT & Software > News
Rio Grande buys Cervel Neurotech’s Multi-Coil TMS technology to treat drug resistant depression
Rio Grande Neurosciences has acquired Cervel Neurotech’s multi-coil Transcranial Magnetic Stimulation (rTMS) technology, including all related patent applications, issued patents, trademarks and equipment.
Automation > IT & Software > News
Enteris BioPharma's formulation technology enables oral delivery of Tarsa Therapeutics' TBRIA
Enteris BioPharma has congratulated Tarsa Therapeutics on the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for TBRIA (calcitonin-salmon [rDNA origin] delayed release tablets) in July 2015, which has now been accepted for review by the FDA with a user fee goal date of May 30, 2016.
Automation > IT & Software > News
Scientists design new delivery system for protease inhibitors
Scientists at the University of Nebraska Medical Center designed a new delivery system for protease inhibitors that, when coupled with a drug developed at the University of Rochester School of Medicine and Dentistry, rid immune cells of HIV and kept the virus in check for long periods.
Automation > IT & Software > News
Emisphere, Novo Nordisk to develop four oral formulations using Eligen technology
By PBR Staff Writer
Emisphere Technologies and Novo Nordisk have entered into an agreement to develop and commercialize oral formulations of four molecules for metabolic disorders.
Automation > IT & Software > News
Sphaera Pharma receives notice of allowance from USPTO for drug modification platform technology
Sphaera Pharma has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its Patent application titled ‘Substituted methylformyl reagents and method of using same to modify physicochemical and/ or pharmacokinetic properties of compounds’, for its platform technology.
Automation > IT & Software > News
Astellas signs deal with Immunomic Therapeutics for worlwide license of LAMP-vax
By PBR Staff Writer
Japan-based Astellas Pharma has signed a deal with the US biotechnology firm Immunomic Therapeutics for an exclusive worldwide license of LAMP-vax products, developed to treat or prevent any allergic diseases in humans.
Automation > IT & Software > News
Symplmed, PuraCap Pharmaceutical team up to distribute new EpiCeram-L Lip Care
Symplmed has entered into an agreement with PuraCap Pharmaceutical to distribute a new product, EpiCeram-L Lip Care, through Symplmed’s patented DyrctAxess technology.
Automation > IT & Software > News
GSK exercises option for inhaled therapeutics from Liquidia Technologies
By PBR Staff Writer
GlaxoSmithKline (GSK) has exercised an option that gives it the exclusive rights to research, develop and commercialize inhaled therapeutics derived from Liquidia Technologies' PRINT technology.
Automation > IT & Software > News
Illumina introduces TruSight Tumor 15 panel
Illumina has launched TruSight Tumor 15, a next-generation sequencing (NGS) panel designed to identify sequence variants in 15 genes commonly associated with marketed therapeutics.
Automation > IT & Software > News
PCORI approves $83m for hepatitis C and other studies
By PBR Staff Writer
The Patient-Centered Outcomes Research Institute (PCORI) has approved $83m to fund 26 patient-centered, comparative clinical effectiveness research (CER) studies on a range of conditions and patient populations.
Automation > IT & Software > News
Eli Lilly and Sanofi settle Basaglar insulin product lawsuit
By PBR Staff Writer
Eli Lilly and Company has entered into a settlement agreement to resolve patent litigation with Sanofi over its Basaglar insulin glargine product.
Automation > IT & Software > News
Syros Pharmaceuticals licenses clinical-stage RARa agonist
Syros Pharmaceuticals has entered into an exclusive license agreement with the Japanese oncology company TMRC, to develop and commercialize tamibarotene in North America and Europe for cancer.
Automation > IT & Software > News
76-90 of 1738 results